- Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
- Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
- HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
Key statistics
On Wednesday, HCW Biologics Inc (HCWB:NMQ) closed at 0.62, 3.33% above its 52-week low of 0.600, set on Jul 02, 2024.
52-week range
Open | 0.62 |
---|---|
High | 0.629 |
Low | 0.62 |
Bid | 0.600 |
Offer | 0.80 |
Previous close | 0.62 |
Average volume | 59.50k |
---|---|
Shares outstanding | 37.82m |
Free float | 18.04m |
P/E (TTM) | -- |
Market cap | 23.45m USD |
EPS (TTM) | -0.7547 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 17:59 BST.
More ▼